Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Suspended × Bevacizumab × Clear all

Phase

Phase 2 3 Phase 1/2 2 Phase 1 2 Phase NA 1

Status

Completed 18 Unknown 7 Recruiting 5 Terminated 4 Not yet recruiting 2 Active not recruiting 2 Withdrawn 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Educational Status 3 Specimen Handling 2 Methods 2 Interviews as Topic 2 Health Promotion 2 Endoscopic Mucosal Resection 2 tocilizumab 1 lopinavir-ritonavir drug combination 1 lavender oil 1 jojoba wax 1 gallium 68 PSMA-11 1 azathiopurine 1 apatinib 1 Transcranial Magnetic Stimulation 1 Tomography, Optical Coherence 1 Therapeutics 1 Surgical Procedures, Operative 1 Standard of Care 1 Radiosurgery 1 Radiofrequency Ablation 1 Quality of Life 1 Practice Guidelines as Topic 1 Positron-Emission Tomography 1 Piperacillin, Tazobactam Drug Combination 1 Physical Therapy Modalities 1 Oxygen Inhalation Therapy 1 Nutritional Status 1 Nephroureterectomy 1 Methylprednisolone 1 Mercaptopurine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03743428 2023-06-29

BABST-C

Shenzhen People's Hospital

Phase NA Suspended

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡